EN DE
Watch Demaecan Co Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Demaecan Co Ltd (YUMSF) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Demaecan Co Ltd stock $0.90, price $1.01, that is 11.5% below the price, quality 46 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical US · Home Japan · ISIN JP3952870008

DC Demaecan Co Ltd logo Thin data Nov 17, 2026

Demaecan Co Ltd

YUMSF · US

Expensive (fair value 12% below the price) and weak company.

Get notified free when this changes
Low debt 
Quality 46/100 
Mixed vs. peers (4/10) 
Fair value $0.8982 · Overvalued 
Weak Growth (revenue 3y −9.4 %/yr in JPY) 
Loss-making · -21.1% net margin (TTM) 
Negative free cash flow 
Narrow moat 9/100
Thin data 
EstimatePrice via web search⚠ Thinly traded
Watch Demaecan Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$41.43 $0.8032 Fair Value $0.8982 Aug 2018 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

60‑month range $0.8032 – $41.43 · fair‑value band $0.6737 – $1.12 · the $1.01 price screens above the $0.8982 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.

Follow Demaecan Co in your weekly email

Every Wednesday you see whether Demaecan Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Demae-Can Co.,Ltd operates delivery-specialized websites and apps in Japan.

Show moreShow less

The company operates Demae-kan, a food delivery service that retails daily necessities, beverages, and other essential items, as well as engages in website operation and management, system development, advertising operation and management, and delivery agency services.

It also offers Demaekan eGift, a gift certificate for dishes, food, and everyday items. The company was formerly known as Yume no Machi Souzou Iinkai Co., Ltd. and changed its name to Demae-Can Co.,Ltd in December 2019.

Demae-Can Co.,Ltd was incorporated in 1999 and is headquartered in Shibuya, Japan.

Stock analysis

Demaecan Co Ltd (YUMSF) currently trades at $1.01, while our estimate is $0.8982, 12% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.6737 (bear) to $1.12 (bull), the price of $1.01 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Consumer Cyclical sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Demaecan Co Ltd reported revenue of ¥38.3B in FY2026 versus ¥47.3B in FY2022, a compound −5.2%/yr. Reported net income was −¥8.1B in FY2026.

Key figures

Market cap $153M Micro · EPS (TTM) $−0.4700 · Net margin −21.1% · Return on equity −33.6% · Return on assets (EBIT) −25.2% (5-year average) · Operating margin −17.8% · Revenue (TTM) ¥39.1B · Revenue growth (YoY) +12.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).

What moves the price

The share trades about 6% above its previous 52-week high, currently above its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at 33% fair-value upside, at −12%, YUMSF screens richer than that median.

Fair Value

Bear $0.6737 Fair Value $0.8982 Bull $1.12
Price $1.01 · Downside -11.5%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 19
How much profit the company makes from its sales and capital
Quality Growth 21
Are margins and returns getting better?
Cashflow 13
Do the profits arrive as real cash?
Financial strength 75
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 52
How calm the share price moves, does not count
Price momentum 63
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 67
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 12/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−3.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.7%
Start year 2021 (pandemic). Over 10 years: +24.9% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−66.2% (2021) → −21.2% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

YUMSF screens overvalued: fair value 12% below the price. Compare with Amazon.com, Inc →

Compare Demaecan Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Internet Retail · 116 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Bottom 25%
Fair Value upside −11.5% · Below median
Profitability
Return on assets −25.9% · Bottom 25%
Net margin (12 months) −21.1% · Bottom 25%
Operating margin (12 months) −17.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 12.7% · Above median

Valuation Multiplesvs Internet Retail median · lower = cheaper

P/B 1.26× · Cheaper than median
P/S (12 months) 0.66× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)18 · sector 41
FUTURE (revenue growth)64 · sector 58
PAST (return on equity)0 · sector 12
HEALTH (low debt)100 · sector 92
DIVIDEND (yield)0 · sector 59

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Internet Retail stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
PDD Holdings PDD $78.11 $234.33 +200% vs YUMSF
Sea Limited SE $71.63 $129.32 +81% vs YUMSF
Prosus N.V PRX €35.38 €53.05 +50% vs YUMSF
JD.com, Inc 9618 HK$108.10 HK$150.34 +39% vs YUMSF
Alibaba Group BABA $90.62 $120.51 +33% vs YUMSF
MercadoLibre, Inc MELI $1,462 $1,830 +25% vs YUMSF
DoorDash, Inc DASH $169.78 $188.66 +11% vs YUMSF
Meituan 3690 HK$71.55 HK$56.62 −21% vs YUMSF
Amazon.com, Inc AMZN $257.75 $140.05 −46% vs YUMSF
eBay Inc EBAY $120.89 $60.00 −50% vs YUMSF

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Demaecan Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Demaecan Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/YUMSF

Frequently asked questions

Is Demaecan Co Ltd (YUMSF) overvalued or undervalued?
As of Nov 17, 2026, our estimate of fair value is $0.8982 versus a price of $1.01, about 12% lower (overvalued).
What is the fair value of YUMSF?
Our estimate for Demaecan Co Ltd is $0.8982 (as of Nov 17, 2026), built from audited fundamentals. The current price: $1.01.
What is the quality score of YUMSF?
Demaecan Co Ltd has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Demaecan Co Ltd (YUMSF)?
Our calculated price target is the estimate of $0.8982 (as of Nov 17, 2026). Cautious scenario $0.6737, optimistic scenario $1.12. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Demaecan Co Ltd stock forecast for 2026?
Our estimate puts fair value at $0.8982, about 12% lower versus a price of $1.01 (overvalued). Cautious scenario $0.6737, optimistic scenario $1.12. The calculation is refreshed regularly with new filings.
What is the revenue of Demaecan Co Ltd (YUMSF)?
Demaecan Co Ltd reported trailing-twelve-month revenue of about ¥39.1B (latest available figure, as of Nov 17, 2026).
What is the intrinsic value of Demaecan Co Ltd (YUMSF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Demaecan Co Ltd it is $0.8982 per share (as of Nov 17, 2026), against a price of $1.01.
Is Demaecan Co Ltd stock overvalued or undervalued in 2026?
As of Nov 17, 2026, YUMSF trades above its calculated fair value: price $1.01, fair value $0.8982, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of YUMSF?
No. The price is what the market pays today ($1.01); the fair value is what the company's own numbers justify ($0.8982). For Demaecan Co Ltd the two are $0.1164 per share apart. That gap is exactly why we show both numbers side by side.
How much is Demaecan Co Ltd worth?
The market values Demaecan Co Ltd at about $153M (market capitalisation, as of Nov 17, 2026). Per share that is $1.01; our models calculate a fair value of $0.8982 per share.
What do the bullish and bearish scenarios say about YUMSF?
Our models span a range for Demaecan Co Ltd: cautious scenario $0.6737, base $0.8982, optimistic $1.12 per share (as of Nov 17, 2026, price $1.01). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Demaecan Co Ltd (YUMSF)?
Balance-sheet figures for Demaecan Co Ltd (as of Nov 17, 2026): return on equity −33.6%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is YUMSF from its 52-week high?
Demaecan Co Ltd trades at $1.01, about 6% above its previous 52-week high of $0.9600 and 33% above the low of $0.7600 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of $0.8982 is for.
Which stocks are comparable to Demaecan Co Ltd?
From the same area (Consumer Cyclical) we also value Amazon.com, Inc, Alibaba Group, PDD Holdings, Prosus N.V, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Demaecan Co Ltd stock attractive at the current price?
The data as of Nov 17, 2026: price $1.01, calculated fair value $0.8982 (−12%), Quality Score 46/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Demaecan Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Demaecan Co Ltd (YUMSF)?
The closing price on Nov 13, 2026 was $1.01. Our estimate is $0.8982, about 12% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Demaecan Co Ltd right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Demaecan Co Ltd

How large is the market capitalisation of Demaecan Co Ltd (YUMSF)?
The market capitalisation of Demaecan Co Ltd is $153M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Demaecan Co Ltd (YUMSF)?
Earnings per share at Demaecan Co Ltd are $−0.4700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Demaecan Co Ltd (YUMSF)?
The net margin of Demaecan Co Ltd is −21.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Demaecan Co Ltd (YUMSF)?
The return on equity (ROE) of Demaecan Co Ltd is −33.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Demaecan Co Ltd (YUMSF)?
On an EBIT basis the return on assets of Demaecan Co Ltd is −25.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Demaecan Co Ltd (YUMSF)?
The operating margin of Demaecan Co Ltd is −17.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Demaecan Co Ltd (YUMSF)?
Revenue at Demaecan Co Ltd is growing 12.7% versus a year earlier (3y avg −9.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Demaecan Co Ltd (YUMSF) generate?
The free cash flow of Demaecan Co Ltd is −¥5.0B (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Demaecan Co Ltd (YUMSF) hold?
Demaecan Co Ltd holds more cash than debt, ¥19.6B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Demaecan Co Ltd in the live analysis

One click puts Demaecan Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.